The anastomosis devices market size has grown strongly in recent years. It will grow from $3.86 billion in 2025 to $4.15 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing volume of gastrointestinal surgeries, rising adoption of surgical stapling techniques, improvements in suture material performance, expansion of minimally invasive surgery adoption, growing hospital surgical capacity.
The anastomosis devices market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for robotic surgical systems, rising focus on faster patient recovery outcomes, expansion of advanced surgical training programs, increasing adoption of disposable surgical devices, technological advancements in automated suturing. Major trends in the forecast period include increasing adoption of automated anastomosis devices, rising use of bioabsorbable sutures and staples, growing preference for minimally invasive surgical closure, expansion of robotic-assisted suturing systems, enhanced focus on leak-prevention technologies.
The increase in the number of surgical procedures is anticipated to drive the expansion of the anastomosis device market in the coming years. Surgical procedures encompass medical practices that involve making incisions in the human body to treat or correct health conditions. The growing volume of these procedures is largely driven by rising demand for medical treatments as well as cosmetic surgeries. Anastomosis devices play a vital role in this trend by allowing surgeons to safely and efficiently join two sections of the body, such as blood vessels or segments of the intestine, during surgical operations. For example, in June 2024, data published by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization, indicated that liposuction continued to be the most commonly performed surgical procedure in 2023, consistent with 2022, with over 2.2 million procedures carried out. Consequently, the rising number of surgical procedures is contributing significantly to the growth of the anastomosis device market.
Leading companies in this sector are focusing on innovation and launching cutting-edge products and technologies to maintain their competitive edge. For example, in May 2024, Ethicon, a U.S.-based medical device company, introduced the ECHELON LINEAR Cutter, a revolutionary surgical stapler designed to improve surgical outcomes by drastically reducing the risk of leaks at the staple line. This innovative device is said to produce 47% fewer leaks compared to conventional staplers, helping to reduce potential complications during and after surgery. The primary goal of the ECHELON Linear Cutter is to lower the incidence of leaks at the staple line, which is essential for ensuring the integrity of tissue closures. Leaks can result in serious complications, including infections and prolonged recovery times.
In March 2024, Advanced Medical Solutions PLC, a medical technology company based in the UK, acquired Peters Surgical for an undisclosed sum. This acquisition is intended to help Advanced Medical Solutions PLC enhance its presence in the operating room, broaden its product portfolio and sales, improve direct selling capabilities, and strengthen its global industrial footprint. Peters Surgical, located in France, specializes in medical technology, particularly in surgical closure devices.
Major companies operating in the anastomosis devices market are Medtronic plc, B. Braun Melsungen AG, Johnson & Johnson Services Inc., Boston Scientific Corp., Baxter International Inc., Meril Life Sciences Pvt. Ltd., Becton Dickinson and Company, Terumo Corporation, Teleflex Incorporated, Getinge AB, LivaNova plc, Stryker Corporation, ConMed Corporation, Grena Ltd., Microline Surgical Inc., Scanlan International Inc., Innovia Medical, Genesee BioMedical Inc., EndoEvolution LLC, Novare Surgical Systems Inc., Dextera Surgical Inc., Intuitive Surgical Inc., Artivion Inc., CryoLife Inc., Cardica Inc., Vascular Graft Solutions Ltd., LifeNet Health Inc.
North America was the largest region in the anastomosis devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global anastomosis devices market report during the forecast period. The regions covered in the anastomosis devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anastomosis devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the anastomosis devices market by increasing costs of imported stainless steel staples, titanium components, precision molding equipment, and robotic system parts. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported surgical devices, while Asia-Pacific faces cost pressure on manufacturing exports. These tariffs are raising procedural costs and impacting device pricing strategies. At the same time, they are encouraging regional manufacturing expansion, localized assembly of surgical devices, and innovation in cost-effective anastomosis solutions.
The anastomosis devices market research report is one of a series of new reports that provides anastomosis devices market statistics, including anastomosis devices industry global market size, regional shares, competitors with a anastomosis devices market share, detailed anastomosis devices market segments, market trends and opportunities, and any further data you may need to thrive in the anastomosis devices industry. This anastomosis devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Anastomosis devices are instruments, either disposable or reusable, designed to create inverted or everted tissue closures using two or more rows of B-shaped stainless steel, titanium, or occasionally absorbable staples. Their purpose is to remove diseased tissues from the body while preventing the leakage of bodily fluids.
The primary categories of anastomosis devices include surgical staplers, surgical sutures, surgical sealants and adhesives, and automated suturing. Surgical staplers are tools employed to close significant surgical wounds or incisions on the scalp or skin, applying staples to various tissues within the body during surgery. They find application in cardiovascular and thoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, and other medical procedures. These devices are utilized in various healthcare settings such as hospitals and ambulatory surgery centers, among others.
The anastomosis devices market consists of sales of cannula, robotics, and incision devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The anastomosis devices market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for robotic surgical systems, rising focus on faster patient recovery outcomes, expansion of advanced surgical training programs, increasing adoption of disposable surgical devices, technological advancements in automated suturing. Major trends in the forecast period include increasing adoption of automated anastomosis devices, rising use of bioabsorbable sutures and staples, growing preference for minimally invasive surgical closure, expansion of robotic-assisted suturing systems, enhanced focus on leak-prevention technologies.
The increase in the number of surgical procedures is anticipated to drive the expansion of the anastomosis device market in the coming years. Surgical procedures encompass medical practices that involve making incisions in the human body to treat or correct health conditions. The growing volume of these procedures is largely driven by rising demand for medical treatments as well as cosmetic surgeries. Anastomosis devices play a vital role in this trend by allowing surgeons to safely and efficiently join two sections of the body, such as blood vessels or segments of the intestine, during surgical operations. For example, in June 2024, data published by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization, indicated that liposuction continued to be the most commonly performed surgical procedure in 2023, consistent with 2022, with over 2.2 million procedures carried out. Consequently, the rising number of surgical procedures is contributing significantly to the growth of the anastomosis device market.
Leading companies in this sector are focusing on innovation and launching cutting-edge products and technologies to maintain their competitive edge. For example, in May 2024, Ethicon, a U.S.-based medical device company, introduced the ECHELON LINEAR Cutter, a revolutionary surgical stapler designed to improve surgical outcomes by drastically reducing the risk of leaks at the staple line. This innovative device is said to produce 47% fewer leaks compared to conventional staplers, helping to reduce potential complications during and after surgery. The primary goal of the ECHELON Linear Cutter is to lower the incidence of leaks at the staple line, which is essential for ensuring the integrity of tissue closures. Leaks can result in serious complications, including infections and prolonged recovery times.
In March 2024, Advanced Medical Solutions PLC, a medical technology company based in the UK, acquired Peters Surgical for an undisclosed sum. This acquisition is intended to help Advanced Medical Solutions PLC enhance its presence in the operating room, broaden its product portfolio and sales, improve direct selling capabilities, and strengthen its global industrial footprint. Peters Surgical, located in France, specializes in medical technology, particularly in surgical closure devices.
Major companies operating in the anastomosis devices market are Medtronic plc, B. Braun Melsungen AG, Johnson & Johnson Services Inc., Boston Scientific Corp., Baxter International Inc., Meril Life Sciences Pvt. Ltd., Becton Dickinson and Company, Terumo Corporation, Teleflex Incorporated, Getinge AB, LivaNova plc, Stryker Corporation, ConMed Corporation, Grena Ltd., Microline Surgical Inc., Scanlan International Inc., Innovia Medical, Genesee BioMedical Inc., EndoEvolution LLC, Novare Surgical Systems Inc., Dextera Surgical Inc., Intuitive Surgical Inc., Artivion Inc., CryoLife Inc., Cardica Inc., Vascular Graft Solutions Ltd., LifeNet Health Inc.
North America was the largest region in the anastomosis devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global anastomosis devices market report during the forecast period. The regions covered in the anastomosis devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anastomosis devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the anastomosis devices market by increasing costs of imported stainless steel staples, titanium components, precision molding equipment, and robotic system parts. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported surgical devices, while Asia-Pacific faces cost pressure on manufacturing exports. These tariffs are raising procedural costs and impacting device pricing strategies. At the same time, they are encouraging regional manufacturing expansion, localized assembly of surgical devices, and innovation in cost-effective anastomosis solutions.
The anastomosis devices market research report is one of a series of new reports that provides anastomosis devices market statistics, including anastomosis devices industry global market size, regional shares, competitors with a anastomosis devices market share, detailed anastomosis devices market segments, market trends and opportunities, and any further data you may need to thrive in the anastomosis devices industry. This anastomosis devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Anastomosis devices are instruments, either disposable or reusable, designed to create inverted or everted tissue closures using two or more rows of B-shaped stainless steel, titanium, or occasionally absorbable staples. Their purpose is to remove diseased tissues from the body while preventing the leakage of bodily fluids.
The primary categories of anastomosis devices include surgical staplers, surgical sutures, surgical sealants and adhesives, and automated suturing. Surgical staplers are tools employed to close significant surgical wounds or incisions on the scalp or skin, applying staples to various tissues within the body during surgery. They find application in cardiovascular and thoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, and other medical procedures. These devices are utilized in various healthcare settings such as hospitals and ambulatory surgery centers, among others.
The anastomosis devices market consists of sales of cannula, robotics, and incision devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Anastomosis Devices Market Characteristics
3. Anastomosis Devices Market Supply Chain Analysis
4. Global Anastomosis Devices Market Trends and Strategies
5. Anastomosis Devices Market Analysis of End Use Industries
7. Global Anastomosis Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Anastomosis Devices Total Addressable Market (TAM) Analysis for the Market
9. Anastomosis Devices Market Segmentation
10. Anastomosis Devices Market Regional and Country Analysis
11. Asia-Pacific Anastomosis Devices Market
12. China Anastomosis Devices Market
13. India Anastomosis Devices Market
14. Japan Anastomosis Devices Market
15. Australia Anastomosis Devices Market
16. Indonesia Anastomosis Devices Market
17. South Korea Anastomosis Devices Market
18. Taiwan Anastomosis Devices Market
19. South East Asia Anastomosis Devices Market
20. Western Europe Anastomosis Devices Market
21. UK Anastomosis Devices Market
22. Germany Anastomosis Devices Market
23. France Anastomosis Devices Market
24. Italy Anastomosis Devices Market
25. Spain Anastomosis Devices Market
26. Eastern Europe Anastomosis Devices Market
27. Russia Anastomosis Devices Market
28. North America Anastomosis Devices Market
29. USA Anastomosis Devices Market
30. Canada Anastomosis Devices Market
31. South America Anastomosis Devices Market
32. Brazil Anastomosis Devices Market
33. Middle East Anastomosis Devices Market
34. Africa Anastomosis Devices Market
36. Anastomosis Devices Market Competitive Landscape and Company Profiles
37. Anastomosis Devices Market Other Major and Innovative Companies
40. Anastomosis Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Anastomosis Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses anastomosis devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for anastomosis devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anastomosis devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Surgical Staplers; Surgical Sutures; Surgical Sealants and Adhesives; Automated Suturing2) By Usage: Disposable; Reusable
3) By Application: Cardiovascular And Thoracic Surgery; Gastrointestinal Surgery; Gynecological Surgery; Other Applications
4) By End-User: Hospitals; Ambulatory Surgery Centers; Other End-Users
Subsegments:
1) By Surgical Staplers: Manual Surgical Staplers; Automated Surgical Staplers; Endoscopic Staplers2) By Surgical Sutures: Absorbable Sutures; Non-Absorbable Sutures; Barbed Sutures
3) By Surgical Sealants And Adhesives: Fibrin Sealants; Tissue Adhesives; Cyanoacrylate Adhesives
4) By Automated Suturing: Linear Cutters; Circular Suturing Devices; Robotic Suturing Systems
Companies Mentioned: Medtronic plc; B. Braun Melsungen AG; Johnson & Johnson Services Inc.; Boston Scientific Corp.; Baxter International Inc.; Meril Life Sciences Pvt. Ltd.; Becton Dickinson and Company; Terumo Corporation; Teleflex Incorporated; Getinge AB; LivaNova plc; Stryker Corporation; ConMed Corporation; Grena Ltd.; Microline Surgical Inc.; Scanlan International Inc.; Innovia Medical; Genesee BioMedical Inc.; EndoEvolution LLC; Novare Surgical Systems Inc.; Dextera Surgical Inc.; Intuitive Surgical Inc.; Artivion Inc.; CryoLife Inc.; Cardica Inc.; Vascular Graft Solutions Ltd.; LifeNet Health Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Anastomosis Devices market report include:- Medtronic plc
- B. Braun Melsungen AG
- Johnson & Johnson Services Inc.
- Boston Scientific Corp.
- Baxter International Inc.
- Meril Life Sciences Pvt. Ltd.
- Becton Dickinson and Company
- Terumo Corporation
- Teleflex Incorporated
- Getinge AB
- LivaNova plc
- Stryker Corporation
- ConMed Corporation
- Grena Ltd.
- Microline Surgical Inc.
- Scanlan International Inc.
- Innovia Medical
- Genesee BioMedical Inc.
- EndoEvolution LLC
- Novare Surgical Systems Inc.
- Dextera Surgical Inc.
- Intuitive Surgical Inc.
- Artivion Inc.
- CryoLife Inc.
- Cardica Inc.
- Vascular Graft Solutions Ltd.
- LifeNet Health Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.15 Billion |
| Forecasted Market Value ( USD | $ 5.64 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
